SCHEMBL9301972

SCHEMBL9301972

CC1CCC2(CC1)CCN(C(P(=O)(O)O)P(=O)(O)O)C2

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9301193 0.80 FDPS (0.53) FDPS
SCHEMBL21886609 0.75 HRH3 (0.35)
SCHEMBL762417 0.75 FDPS (0.56) FDPS
SCHEMBL9301189 0.73 FDPS (0.58) FDPS
SCHEMBL9302201 0.73 FDPS (0.59) FDPS
SCHEMBL9300273 0.73 FDPS (0.64) FDPS
SCHEMBL9301543 0.70 FDPS (0.59) FDPS
SCHEMBL9300487 0.68 FDPS (0.63) FDPS
SCHEMBL15316686 0.67 CYP2D6 (0.37)
SCHEMBL9302739 0.67 FDPS (0.56) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed